Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 486 participants.
Also called NCT01121107
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 486 participants
- Sponsor
- Registry
-
NCT01121107
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, New Zealand
- Registry status
- Completed
Technical summary
Registry record NCT01121107. Randomized; no masking; primary purpose diagnostic. Start 2010-04 (registry gives no type); primary completion 2015-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
- Acronym
- LAPTOP-HF
- Condition
- Heart Failure
- Intervention (Device)
- Left Atrial Pressure Monitoring System
- Intervention (Device)
- Patient Advisory Module
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01121107- Content hash
5c180a5ed139b1401b63cf55e45dcd8835df08a9500c4dca6c70b75217c2e697